Nerea Moreno Cervera

Title: Nerea Moreno Cervera: Innovator in Oligonucleotide Research

Introduction

Nerea Moreno Cervera is a prominent inventor based in Valencia, Spain. She has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide-based therapies. Her innovative work focuses on the modulation of microRNAs, which play crucial roles in various biological processes.

Latest Patents

Nerea holds a patent for "Oligonucleotides conjugated to oleic acid and uses thereof." This invention provides oligonucleotide and/or oligonucleotide analogue molecules that act as antagonists of specific human microRNAs, namely hsa-miR-23b-3p and hsa-miR-218-5p. The oligonucleotides comprise a mixture of phosphorothioate and phosphodiester linkages and are conjugated to oleic acid molecules. By inhibiting these microRNAs, her invention aims to increase the endogenous levels of the corresponding proteins MBNL1 and/or MBNL2. Furthermore, the invention includes compositions comprising these oligonucleotides and their applications for the treatment and prevention of diseases in subjects in need.

Career Highlights

Throughout her career, Nerea has worked with esteemed institutions such as Universitat De Valencia and Arthex Biotech S.L. Her research has garnered attention for its potential therapeutic applications, particularly in the field of molecular medicine.

Collaborations

Nerea has collaborated with notable colleagues, including Rubén Artero Allepuz and Irene González Martínez. These partnerships have contributed to the advancement of her research and the successful development of her patented technologies.

Conclusion

Nerea Moreno Cervera is a trailblazer in the field of oligonucleotide research, with a focus on innovative therapies targeting microRNAs. Her contributions have the potential to impact the treatment of various diseases significantly.